A064550 Stock Overview
Bioneer Corporation operates as a biotechnology company in South Korea, the Americas, Europe, Asia, Africa, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Bioneer Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩30,100.00 |
| 52 Week High | ₩77,600.00 |
| 52 Week Low | ₩23,950.00 |
| Beta | -0.94 |
| 1 Month Change | -8.93% |
| 3 Month Change | 14.02% |
| 1 Year Change | -48.19% |
| 3 Year Change | 60.53% |
| 5 Year Change | 198.02% |
| Change since IPO | 116.55% |
Recent News & Updates
Recent updates
Lacklustre Performance Is Driving Bioneer Corporation's (KOSDAQ:064550) Low P/S
Mar 06
Bioneer (KOSDAQ:064550) Seems To Use Debt Quite Sensibly
Mar 25Bioneer Corporation's (KOSDAQ:064550) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 15Investors Who Bought Bioneer (KOSDAQ:064550) Shares A Year Ago Are Now Up 166%
Jan 20
Is Bioneer (KOSDAQ:064550) A Risky Investment?
Dec 24Here's Why We Think Bioneer's (KOSDAQ:064550) Statutory Earnings Might Be Conservative
Nov 28Shareholder Returns
| A064550 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | 10.7% | 0.3% | -0.4% |
| 1Y | -48.2% | 5.7% | 4.5% |
Return vs Industry: A064550 underperformed the KR Biotechs industry which returned 5.7% over the past year.
Return vs Market: A064550 underperformed the KR Market which returned 4.5% over the past year.
Price Volatility
| A064550 volatility | |
|---|---|
| A064550 Average Weekly Movement | 8.8% |
| Biotechs Industry Average Movement | 8.4% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A064550 has not had significant price volatility in the past 3 months.
Volatility Over Time: A064550's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 606 | Han-Oh Park | www.bioneer.co.kr |
Bioneer Corporation operates as a biotechnology company in South Korea, the Americas, Europe, Asia, Africa, and internationally. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer and solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide function, and magnetic separation services, as well as instruments for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and vortex mixer, and electrophoresis. It also provides molecular diagnosis, including MDx technologies, human diagnostics kits, MDx extraction kits, and instruments; and products for animal, aquatic-bio, mosquito-borne, and plant diseases, as well as food safety, human pathogen, and nano-bio products.
Bioneer Corporation Fundamentals Summary
| A064550 fundamental statistics | |
|---|---|
| Market cap | ₩776.89b |
| Earnings (TTM) | -₩10.59b |
| Revenue (TTM) | ₩263.24b |
3.0x
P/S Ratio-73.4x
P/E RatioIs A064550 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A064550 income statement (TTM) | |
|---|---|
| Revenue | ₩263.24b |
| Cost of Revenue | ₩60.74b |
| Gross Profit | ₩202.50b |
| Other Expenses | ₩213.09b |
| Earnings | -₩10.59b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -410.19 |
| Gross Margin | 76.93% |
| Net Profit Margin | -4.02% |
| Debt/Equity Ratio | 17.8% |
How did A064550 perform over the long term?
See historical performance and comparison